In light of the data indicating that galectin-3 does not correlate with age in healthy children [17,18], it is becoming a new, promising tool in the diagnosis of such cardiovascular system disorders as a heart failure, cardiomyopathies, inflammatory diseases, or congenital heart diseases. Here, LGALS3 is linked to heart failure.